810 results found
The Statement on Sex, Gender, Variations of Sex Characteristics and Sexual Orientation in Health and Medical Research (the Statement) is a joint initiative of NHMRC and the Department of Health, Disability and Ageing (responsible for implementation of the Medical Research Future Fund (MRFF)).The Statement was developed in partnership with stakeholders, including researchers, consumers and advocacy groups with experience and expertise in consideration of sex, gender, variations of sex characteristics and sexual orientation in health and medical research. The diverse perspectives, experiences and knowledge of women and men, both cisgender and trans, non-binary people, people with innate variations of sex characteristics and people with diverse sexual orientations are valued, respected, and contributed to the final Statement. A PDF version of the Statement is available to download.The Statement was last updated in late 2025 to align with it being embedded in the NHMRC and MRFF grant programs from 2026.
Discover how Professor Allison Cowin's innovative stem cell and antibody treatments are transforming chronic wound care. Her groundbreaking work offers hope and improved health outcomes for millions worldwide.
MRFF – Stem Cell Therapies Mission – 2025 Stem Cell Therapies Grant Opportunity
The translation of health and medical research provides the best opportunity for populations to receive excellent health care, and drives advances and breakthroughs in health care in Australia.
Professor Erica Wood is head of the Transfusion Unit at Monash University. Her research describes how blood is used in Australia, and how its use can be improved and made safer and more cost-effective. Through registry data and clinical trials, and studies of novel blood products, Professor Wood and her team aim to improve access and transfusion outcomes for patients.
Dr Jeffrey Liddell from the University of Melbourne is a mid-career neurobiologist, with an interest in neurodegenerative diseases and understanding their underlying causes.
As a practising optometrist, Associate Professor Zhichao Wu realised there was a big problem diagnosing glaucoma. Glaucoma is a leading cause of irreversible vision loss that is projected to cost Australia $4.3 billion per annum by 2025.
The average adult takes up to 20 breaths every minute, something most people give little thought. However, breathing can be a daily struggle for people with Chronic Obstructive Pulmonary Disease (COPD),an umbrella term for a group of lung conditions that includes emphysema, chronic bronchitis and chronic asthma.
Recipient of the 2025 NHMRC Consumer Involvement Award, Professor James St John is a translational neuroscientist specialising in the creation and delivery of therapies to repair injuries and diseases of the nervous system. He has driven the development of a comprehensive consumer involvement program to design and create a cell transplantation therapy for repairing chronic spinal cord injury which is now progressing to a clinical trial.
We recognise that uncertainty about the trajectory and ongoing impacts of the COVID-19 pandemic continues to affect many in Australia’s health and medical research community.
Human Research Ethics Committees (HRECs) review research proposals involving human participants to ensure that they are ethically acceptable. There are approximately 200 HRECs in research organisations across Australia or operating independently.